EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Pier Luigi Filosso
Giovanni Donati
Giuliano Maggi
Enrico Ruffini
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rena, O.
Right arrow Articles by Ruffini, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rena, O.
Right arrow Articles by Ruffini, E.
Related Collections
Right arrow Lung - cancer

Eur J Cardiothorac Surg 2002;21:514-519
© 2002 Elsevier Science NL

Stage I non-small cell lung carcinoma: really an early stage?

Ottavio Rena*, Alberto Oliaro, Antonio Cavallo, Pier Luigi Filosso, Giovanni Donati, Paolo Di Marzio, Giuliano Maggi, Enrico Ruffini

Department of Thoracic Surgery, University of Torino, San Giovanni Battista Hospital, v. Genova 3, 10126 Turin, Italy

Received 17 September 2001; received in revised form 5 December 2001; accepted 10 December 2001.

* Corresponding author. Tel.: +39-011-633-6775; fax: +39-011-696-0170
e-mail: ottavio.rena{at}tiscalinet.it

Objective: We review our results on surgical treatment of patients with stage I non-small cell lung carcinoma and we attempted to clarify the prognostic significance of some surgical–pathologic variables. Methods: From 1993 to 1999, 667 patients received curative lung resection and complete hilar and mediastinal lymphadenectomy for non-small cell lung cancer. Of these, there were 436 Stage I disease (65%), of whom 144 T1N0 and 292 T2N0. No patients had pre- or postoperative radio- or chemotherapy. Prognostic significance of the following independent variables was tested using univariate (log-rank) and multivariate (Cox proportional-hazards) analysis: type of resection (sublobar vs lobectomy vs pneumonectomy), histology (squamous cell vs adenocarcinoma), tumour size (<=3 cm vs >3 cm), histologic vascular invasion, visceral pleura involvement, positive bronchial resection margin, general T status. Results: Overall 5-year survival was 63%. In both univariate and multivariate survival analysis, significant prognostic factors were histology (adenocarcinoma 65% vs squamous cell carcinoma 51%), tumour size (<=3 cm 67% vs >3 cm 46%), and the presence of negative resection margin. Five-year survival by general T status was 66% in T1N0 vs 55% in T2N0 disease (P=0.19). Conclusions: Despite advances in early diagnosis and surgical technique, 5-year survival of stage I non-small cell lung carcinoma remains low as compared to survival of other solid organ neoplasm. Tumour size <=3 cm, adenocarcinoma histologic type and negative bronchial resection margins were associated with a more favourable outcome in our patient population. More effective multimodality treatments are needed to increase survival rates.

Key Words: Early-stage non-small cell lung cancer • Stage I non-small cell lung cancer • Surgery




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
O. Rena, L. Carsana, S. Cristina, E. Papalia, F. Massera, L. Errico, C. Bozzola, and C. Casadio
Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance
Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 863 - 867.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P.-K. Hsu, H.-C. Huang, C.-C. Hsieh, H.-S. Hsu, Y.-C. Wu, M.-H. Huang, and W.-H. Hsu
Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer
Ann. Thorac. Surg., December 1, 2007; 84(6): 1825 - 1829.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W.-H. Hsu, C.-S. Huang, H.-S. Hsu, W.-J. Huang, H.-C. Lee, B.-S. Huang, and M.-H. Huang
Preoperative Serum Carcinoembryonic Antigen Level is a Prognostic Factor in Women With Early Non-Small-Cell Lung Cancer
Ann. Thorac. Surg., February 1, 2007; 83(2): 419 - 424.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Riquet, C. Foucault, P. Berna, J. Assouad, A. Dujon, and C. Danel
Prognostic Value of Histology in Resected Lung Cancer With Emphasis on the Relevance of the Adenocarcinoma Subtyping
Ann. Thorac. Surg., June 1, 2006; 81(6): 1988 - 1995.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. B. Flieder, J. L. Port, R. J. Korst, P. J. Christos, M. A. Levin, D. E. Becker, and N. K. Altorki
Tumor Size Is a Determinant of Stage Distribution in T1 Non-Small Cell Lung Cancer
Chest, October 1, 2005; 128(4): 2304 - 2308.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
O. A. Khan, J. J. Fitzgerald, M. L. Field, I. Soomro, F. D. Beggs, W. E. Morgan, and J. P. Duffy
Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung
Ann. Thorac. Surg., April 1, 2004; 77(4): 1173 - 1178.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. L. Port, M. S. Kent, R. J. Korst, D. Libby, M. Pasmantier, and N. K. Altorki
Tumor Size Predicts Survival Within Stage IA Non-Small Cell Lung Cancer
Chest, November 1, 2003; 124(5): 1828 - 1833.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.